Chonluten is a synthetic tripeptide bioregulator (L-Glu-L-Asp-L-Arg) investigated in preclinical models for its role in modulating pro-inflammatory signaling pathways, particularly the transcriptional downregulation of Interleukin-6 (IL-6). PX1 Research supplies high-purity, laboratory-grade Chonluten verified by HPLC and mass spectrometry for rigorous in vitro and ex vivo analytical applications.
Chonluten is a synthetic tripeptide bioregulator (L-Glu-L-Asp-L-Arg) investigated in preclinical models for its role in modulating pro-inflammatory signaling pathways, particularly the transcriptional downregulation of Interleukin-6 (IL-6). PX1 Research supplies high-purity, laboratory-grade Chonluten verified by HPLC and mass spectrometry for rigorous in vitro and ex vivo analytical applications.
Researchers seeking to buy interleukin6 reduction chonluten reagents acquire a short synthetic tripeptide (Glu-Asp-Arg) evaluated in preclinical models for its ability to suppress hyper-inflammatory cytokine production. In vitro assays demonstrate that Chonluten modulates gene expression in bronchial epithelial tissues, leading to measurable reductions in Interleukin-6 (IL-6) mRNA transcripts and secreted protein levels under stress conditions.
As an short-chain peptide bioregulator, Chonluten acts directly at the chromatin level by binding to specific DNA sequences in promoter regions of inflammatory genes. Laboratory teams investigating pulmonary cellular homeostasis, epithelial barrier integrity, and acute inflammatory responses utilize this compound to dissect the molecular mechanisms governing cytokine downregulation.
Chonluten is defined by the primary amino acid sequence L-glutamyl-L-aspartyl-L-arginine (Glu-Asp-Arg, or EDR). With a low molecular mass of approximately 388.38 g/mol, this tripeptide belongs to the Khavinson class of short peptide bioregulators derived from lung and respiratory tissue extracts. The specific charge distribution provided by the acidic side chains of glutamic acid and aspartic acid alongside the basic guanidino group of arginine enables high-affinity interaction with targeted nucleoprotein structures.
In physiological buffers, Chonluten exhibits superior solubility and chemical stability relative to larger polypeptide constructs. Researchers interested in exploring broader bioregulatory pathways can view our complete catalog of research peptides to compare structural properties, sequence lengths, and biochemical behaviors across different organ-specific short-chain peptides.
Interleukin-6 (IL-6) serves as a primary driver of systemic inflammation and acute-phase pulmonary responses. In preclinical studies evaluating inflammatory lung tissue models, exposure to lipopolysaccharides (LPS) or oxidative stress triggers a significant elevation in nuclear factor kappa B (NF-κB) transcription factors, subsequently driving IL-6 promoter activation. Preclinical data indicate that the administration of Chonluten attenuates this signaling cascade, significantly reducing downstream IL-6 expression.
Chromatin immunoprecipitation and nuclear binding assays suggest that Glu-Asp-Arg penetrates both cell membranes and nuclear envelopes to interact with histones and specific DNA motif sequences. By altering chromatin condensation and hindering the recruitment of co-activators to the IL-6 gene promoter region, Chonluten exerts a direct transcriptomic suppressive effect. To examine primary literature summaries regarding pulmonary bioregulator mechanisms, visit the PX1 Research library hub.
The primary focus of Chonluten research centers on bronchial epithelial cells, alveolar macrophage cultures, and isolated tracheal tissue explants. In vitro studies using human bronchial epithelial cell lines (such as BEAS-2B) have established that pretreatment with Chonluten limits the release of IL-6, Interleukin-8 (IL-8), and Tumor Necrosis Factor-alpha (TNF-α) following challenged exposure to microparticulate or chemical irritants.
Furthermore, animal models of acute lung injury (ALI) demonstrate that systemic or aerosolized administration of Glu-Asp-Arg yields reduced pulmonary edema, decreased neutrophil infiltration into bronchoalveolar lavage fluid (BALF), and restored surfactant protein expression. Researchers studying respiratory pathophysiology can review technical documentation on our dedicated Chonluten product page to analyze specifications tailored to epithelial research protocols.
When designing cytokine modulation assays, laboratory investigators frequently compare Chonluten against other bioregulatory tripeptides and dipeptides targeted at mucosal or immune tissues. Understanding structural and functional distinctions allows researchers to select the precise tool required for their analytical endpoints.
The primary short-chain peptides investigated alongside Chonluten include:
• Bronchogen research insights: A synthetic tetrapeptide (Ala-Glu-Asp-Leu) specifically studied for modulating bronchial smooth muscle remodeling and goblet cell differentiation alongside cytokine suppression. • Thymogen immune modulation: A dipeptide (Glu-Trp) focused primarily on T-lymphocyte differentiation and systemic immunomodulation rather than targeted pulmonary epithelial protection. • Chonluten lung tissue bioregulator: The Tripeptide Glu-Asp-Arg, which exhibits highly targeted activity on IL-6 transcript repression within airway epithelial cell lines.
While Thymogen exerts broader immunomodulatory effects across peripheral blood mononuclear cells (PBMCs), Chonluten exhibits localized potency in airway epithelial models, making it the preferred compound for targeted IL-6 suppression research.
To preserve the structural integrity and bioactivity of synthetic Chonluten during laboratory procedures, proper solubilization techniques must be strictly maintained. The lyophilized peptide cake should be brought to room temperature prior to reconstitution to avoid moisture condensation inside the vial.
Reconstitution should be performed using sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or sterile water for injection, depending on the requirements of the downstream cell culture assay. Gentle swirling or slow inversion is recommended; vigorous vortexing should be avoided to prevent protein shearing or foaming. Detailed operational guidelines can be found in our peptide reconstitution guide.
Lyophilized Chonluten powder demonstrates optimal stability when stored at -20°C in a desiccated environment, shielded from light exposure. Under these conditions, the molecular structure remains intact without significant hydrolytic degradation for extended storage periods.
Once reconstituted into aqueous solution, aliquots should be used immediately or stored at -80°C to minimize degradation over time. Repeated freeze-thaw cycles must be avoided, as phase changes can cause peptide aggregation or loss of target binding efficiency in high-sensitivity IL-6 ELISA assays.
When sourcing reagents to buy interleukin6 reduction chonluten compounds for quantitative scientific research, verifying chemical purity and freedom from biological contaminants is essential. Inferior synthetic peptides containing truncated sequences or residual chemical scavengers will skew cellular response data and yield irreproducible cytokine measurements.
PX1 Research enforces stringent quality control mandates for every manufactured lot. Every lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm peptide purity exceeding 98.0%, combined with Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight match (388.38 Da). Laboratories requiring larger quantities for multi-phase screening programs can register for a wholesale lab account to access volume pricing and automated COA dispatch.
Because Interleukin-6 assays are hyper-sensitive to lipopolysaccharide contamination, purchasing peptides with low endotoxin levels is critical. Bacterial endotoxins naturally induce robust IL-6 expression in cellular models, creating false positives that undermine baseline experimental controls.
PX1 Research conducts kinetic Chromogenic LAL (Limulus Amebocyte Lysate) testing on every lot to guarantee endotoxin levels remain below 0.1 EU/mg. All testing is conducted within ISO 17025 accredited analytical facilities, and lot-specific Certificates of Analysis (COAs) are available for download. Learn more about our rigorous testing protocols in our guide on endotoxin testing standards.
PX1 Research is an established USA-based manufacturer dedicated exclusively to supplying research-grade peptides to academic institutions, biotechnology firms, and contract research organizations (CROs). We maintain full domestic oversight over synthesis, purification, packaging, and quality control.
Orders are dispatched directly from our dual logistical centers in California and Arizona, providing rapid fulfillment with same-day shipping on all orders placed before 3:00 PM EST, Monday through Friday. Every vial is delivered with full lot traceability, assuring institutional researchers of batch-to-batch consistency and total analytical compliance.
What is Chonluten and how does it relate to Interleukin-6 reduction?
Chonluten is a synthetic tripeptide (Glu-Asp-Arg) studied in preclinical models for its ability to downregulate pro-inflammatory cytokine expression, specifically Interleukin-6 (IL-6), in bronchial epithelial cells.
What is the primary sequence and molecular weight of Chonluten?
Chonluten has the primary amino acid sequence L-glutamyl-L-aspartyl-L-arginine (Glu-Asp-Arg / EDR) with a monoisotopic molecular weight of approximately 388.38 g/mol.
Are PX1 Research peptides intended for human consumption or therapeutic use?
No. All compounds supplied by PX1 Research, including Chonluten, are strictly intended for laboratory research, in vitro assays, and ex vivo experimental procedures. They are not for human or clinical use.
How is Chonluten tested for purity and identity at PX1 Research?
Each lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify >98% purity, alongside Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact molecular identity.
What are the endotoxin limits for PX1 Research Chonluten?
PX1 Research enforces strict endotoxin screening using kinetic LAL assays, ensuring endotoxin levels are verified below 0.1 EU/mg to prevent background inflammatory activation in cell culture models.
What solvents should be used to reconstitute Chonluten for laboratory assays?
Chonluten is highly water-soluble and can be reconstituted using sterile Bacteriostatic Water, sterile Phosphate-Buffered Saline (PBS), or sterile water for injection, depending on experimental protocols.
What are the recommended storage conditions for Chonluten?
Lyophilized powder should be stored at -20°C in a dry, dark place. Once reconstituted, liquid aliquots should be stored at -80°C to minimize degradation and avoid repeated freeze-thaw cycles.
Where does PX1 Research manufacture and ship its research compounds?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment hubs in California and Arizona with same-day dispatch for orders placed by 3:00 PM EST, M–F.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.